Format

Send to

Choose Destination
Acta Derm Venereol. 2017 Feb 8;97(2):149-158. doi: 10.2340/00015555-2496.

A Review of International Recommendations for the Diagnosis and Management of Chronic Urticaria.

Author information

1
Department of Dermatology, University of Rochester Medical Center, 14642 Rochester, USA. Lisa_Beck@URMC.Rochester.edu.

Abstract

Both spontaneous and inducible forms of chronic urticaria pose a significant economic burden and have an adverse effect on patients' quality of life. The international guidelines and US practice parameters for the diagnosis and management of chronic urticaria both recommend performing a thorough patient history and physical examination, conducting limited routine laboratory testing, and taking a stepwise approach to treatment. These documents differ in several areas, such as the order of diagnostic procedures and the treatment for patients non-responsive to standard dose H1-antihistamines. Patients with chronic urticaria who visit a specialist have typically been treated with second-generation H1-antihistamines - the recommended first-line treatments. The advantages and disadvantages of each treatment option should be taken into consideration when selecting therapies beyond H1-antihistamines. Greater awareness of the international guidelines and US practice parameters will likely improve the quality of care for patients with chronic urticaria.

PMID:
27349620
DOI:
10.2340/00015555-2496
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Medical Journals
Loading ...
Support Center